Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT.
Détails
ID Serval
serval:BIB_0AABFE5FA7A4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT.
Périodique
Endocrine
ISSN
1559-0100 (Electronic)
ISSN-L
1355-008X
Statut éditorial
Publié
Date de publication
06/2013
Peer-reviewed
Oui
Volume
43
Numéro
3
Pages
729-731
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Cisplatin/therapeutic use, Etoposide/therapeutic use, Female, Fluorodeoxyglucose F18, Humans, Middle Aged, Neoplasm Grading, Neoplasm Staging, Neuroendocrine Tumors/diagnostic imaging, Neuroendocrine Tumors/drug therapy, Neuroendocrine Tumors/secondary, Pancreatic Neoplasms/diagnostic imaging, Pancreatic Neoplasms/drug therapy, Pancreatic Neoplasms/pathology, Peptides, Cyclic/therapeutic use, Radionuclide Imaging, Somatostatin/analogs & derivatives, Somatostatin/therapeutic use, Treatment Outcome
Pubmed
Web of science
Création de la notice
20/08/2017 21:11
Dernière modification de la notice
20/08/2019 13:32
Données d'usage
